Acute decompensated heart failure: formulating an evidence-based approach to diagnosis and treatment (part II).

No abstract is available for this paper.

• Publication year

  2006

• Venue

  The Mount Sinai journal of medicine, New York

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 16568194
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nesiritide and worsening of renal function: the emperor's new clothes?

  2005cited by this paper
• Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.

  2005cited by this paper
• Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart Failure

  2005cited by this paper
• Observation unit treatment of heart failure with nesiritide: results from the proaction trial.

  2005cited by this paper
• Impact of Nesiritide on Health Care Resource Utilization and Complications in Patients with Decompensated Heart Failure

  2004cited by this paper
• Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

  2004cited by this paper
• Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.

  2004cited by this paper
• Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.

  2004cited by this paper
• Continuous versus bilevel positive airway pressure in acute cardiogenic pulmonary edema? A good question!

  2004cited by this paper
• Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.

  2004cited by this paper
• Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema*

  2004cited by this paper
• Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.

  2004cited by this paper
• LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study.

  2003cited by this paper
• Hemodynamic response to intensive unloading therapy (furosemide and nitroprusside) in patients >70 years of age with left ventricular systolic dysfunction and decompensated chronic heart failure.

  2003cited by this paper
• Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure.

  2003cited by this paper
• Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure.

  2003cited by this paper
• Mechanisms and management of diuretic resistance in congestive heart failure

  2003cited by this paper
• Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

  2003cited by this paper
• Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

  2002cited by this paper
• Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

  2002cited by this paper
• BG9719 (CVT-124), an A1 Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy

  2002cited by this paper
• The puzzle of nitrate tolerance: pieces smaller than we thought?

  2002cited by this paper
• B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea.

  2002cited by this paper
• Intravenous nesiritide (human B-type natriuretic peptide) reduces plasma endothelin-1 levels in patients with decompensated congestive heart failure.

  2002cited by this paper
• Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure.

  2001cited by this paper
• Prevention of venous thromboembolism.

  2001cited by this paper
• Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects.

  2001cited by this paper
• Aggressive diuresis for severe heart failure in the elderly.

  2001cited by this paper
• Socioeconomic status as an independent risk factor for hospital readmission for heart failure.

  2001cited by this paper
• Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

  2000cited by this paper
• L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock.

  2000cited by this paper
• The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

  2000cited by this paper
• Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

  2000cited by this paper
• Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial.

  2000cited by this paper
• Prevention of Venous Thromboembolism in Internal Medicine with Unfractionated or Low-molecular-weight Heparins: A Meta-analysis of Randomised Clinical Trials

  2000cited by this paper
• Diuretic treatment and diuretic resistance in heart failure.

  1999cited by this paper
• Bolus versus Continuous Low Dose of Enalaprilat in Congestive Heart Failure with Acute Refractory Decompensation

  1999cited by this paper
• A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

  1999cited by this paper
• Inotropic infusions for chronic congestive heart failure: medical miracles or misguided medicinals?

  1999cited by this paper
• Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

  1999cited by this paper
• Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.

  1999cited by this paper
• Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.

  1998cited by this paper
• Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.

  1998cited by this paper
• A prediction rule to identify low-risk patients with community-acquired pneumonia.

  1997cited by this paper
• Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema.

  1997cited by this paper
• Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

  1996cited by this paper
• Correlates of major complications or death in patients admitted to the hospital with congestive heart failure.

  1996cited by this paper
• Placebo-controlled, randomized, double-blind study of intravenous enalaprilat efficacy and safety in acute cardiogenic pulmonary edema.

  1996cited by this paper
• Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial.

  1996cited by this paper
• Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Short-term results and long-term follow-up.

  1995cited by this paper
• Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance.

  1995cited by this paper
• A Time‐Insensitive Predictive Instrument for Acute Hospital Mortality Due to Congestive Heart Failure: Development, Testing, and Use for Comparing Hospitals A Multicenter Study

  1994cited by this paper
• Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure.

  1993cited by this paper
• Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask.

  1991cited by this paper
• Counter‐Regulatory Responses to Continuous and Intermittent Therapy With Nitroglycerin

  1991cited by this paper
• Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure.

  1991cited by this paper
• Sublingual administration of captopril versus nitroglycerin in patients with severe congestive heart failure.

  1990cited by this paper
• Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine.

  1990cited by this paper
• The triage decision in pulmonary edema

  1988cited by this paper
• Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

  1987cited by this paper
• Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.

  1985cited by this paper
• Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis.

  1985cited by this paper
• Effect of sublingual nitroglycerin in emergency treatment of severe pulmonary edema.

  1978cited by this paper
• Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts).

  1976cited by this paper

• [Acute heart failure].

  2012cites this paper
• Ultrassonografia pulmonar na insuficiência cardíaca agudamente descompensada Pulmonary ultrasonography in acute decompensated heart failure

  2010cites this paper